Morgan Stanley Evolus, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Evolus, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,000,549 shares of EOLS stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000,549

Previous 1,480,713 32.43%

Holding current value

$10.9 Million

Previous $16.1 Million 0.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.66 - $17.48 $5.12 Million - $8.39 Million	-480,164 Reduced 32.43%	1,000,549 $16.2 Million
Q2 2024 Oct 17, 2024	SELL	$10.45 - $13.76 $16.3 Million - $21.5 Million	-1,562,090 Reduced 51.34%	1,480,713 $16.1 Million
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $16.3 Million - $21.5 Million	-1,562,090 Reduced 51.34%	1,480,713 $16.1 Million
Q1 2024 Oct 17, 2024	BUY	$9.99 - $14.91 $15.6 Million - $23.3 Million	1,562,090 Added 105.5%	3,042,803 $42.6 Million
Q1 2024 Aug 16, 2024	BUY	$9.99 - $14.91 $4.6 Million - $6.86 Million	460,092 Added 17.81%	3,042,803 $42.6 Million
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $4.6 Million - $6.86 Million	460,092 Added 17.81%	3,042,803 $42.6 Million
Q4 2023 Aug 16, 2024	BUY	$7.6 - $10.53 $8.38 Million - $11.6 Million	1,101,998 Added 74.42%	2,582,711 $27.2 Million
Q4 2023 Feb 13, 2024	BUY	$7.6 - $10.53 $15.6 Million - $21.7 Million	2,056,136 Added 390.47%	2,582,711 $27.2 Million
Q3 2023 Nov 15, 2023	BUY	$7.15 - $10.2 $1.95 Million - $2.79 Million	273,426 Added 108.01%	526,575 $4.81 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $1 Million - $1.46 Million	138,885 Added 121.55%	253,149 $1.84 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $426,730 - $603,760	54,639 Added 91.64%	114,264 $966,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $22,005 - $30,206	-3,375 Reduced 5.36%	59,625 $447,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $917,123 - $1.62 Million	-118,186 Reduced 65.23%	63,000 $507,000
Q2 2022 Oct 27, 2022	BUY	$10.22 - $13.94 $1.32 Million - $1.81 Million	129,570 Added 251.03%	181,186 $2.1 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $1.32 Million - $1.81 Million	129,570 Added 251.03%	181,186 $2.1 Million
Q1 2022 Oct 27, 2022	SELL	$5.22 - $11.78 $676,355 - $1.53 Million	-129,570 Reduced 71.51%	51,616 $579,000
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $78,613 - $177,406	-15,060 Reduced 22.59%	51,616 $579,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $776,399 - $1.21 Million	-144,581 Reduced 68.44%	66,676 $434,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $1.55 Million - $2.89 Million	211,257 New	211,257 $1.61 Million

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account